A review of India's Generalized System of Preferences eligibility based on issues surrounding its compliance with the GSP market access criterion was initiated by the US Trade Representative after US industry groups, including AdvaMed, filed petitions for a review of the country's GSP benefits. Representatives from the trade body, who wanted stent price cuts be reviewed by the Indian government, visited the country last week.
GSP eligibility review of India launched by US Trade Rep
Sign up for AdvaMed SmartBrief
Medical technology news
Get the intelligence you need: news and information that is changing your industry today, hand-curated by our professional editors from thousands of sources and delivered straight to your inbox.